Q1 2014 Holdings
Filed 2014-05-14 | 64 holdings | $272.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec Inc(BIIB) | COMMON | 09062X103 | $164.1M | 536,393 | 60.3% |
| Biomarin Pharmac Inc(BMRN) | COMMON | 09061G101 | $63.3M | 927,406 | 23.2% |
| Abbvie Inc(ABBV) | COMMON | 00287Y109 | $14.1M | 273,979 | 5.2% |
| Boston Scientific(BSX) | COMMON | 101137107 | $13.8M | 1,019,221 | 5.1% |
| Align Tech Inc(ALGN) | COMMON | 016255101 | $10.2M | 197,072 | 3.7% |
| Accuray Inc(ARAY) | COMMON | 004397105 | $4.6M | 483,739 | 1.7% |
| Amgen Inc(AMGN) | COMMON | 031162100 | $173.3K | 1,405,062 | 0.1% |
| Gilead Sciences Inc(GILD) | COMMON | 375558103 | $145.8K | 2,057,416 | 0.1% |
| Thermo Fisher SCI(TMO) | COMMON | 883556102 | $94.4K | 785,500 | 0.0% |
| Regeneron Pharmctcls(REGN) | COMMON | 75886F107 | $92.3K | 307,400 | 0.0% |
| Vertex Pharmaceuticl(VRTX) | COMMON | 92532F100 | $90.3K | 1,276,741 | 0.0% |
| Alexion Pharm Inc(ALXN) | COMMON | 015351109 | $83.4K | 548,008 | 0.0% |
| Celgene Corp(CELG) | COMMON | 151020104 | $79.0K | 566,236 | 0.0% |
| Teva Pharmaceutical(TEVA) | ADR | 881624209 | $76.2K | 1,441,992 | 0.0% |
| Incyte Corporation(INCY) | COMMON | 45337C102 | $75.1K | 1,403,160 | 0.0% |
| Halozyme Therapeutic(HALO) | COMMON | 40637H109 | $68.0K | 5,355,488 | 0.0% |
| Mylan Inc | COMMON | 628530107 | $67.9K | 1,390,697 | 0.0% |
| Allergan Inc | COMMON | 018490102 | $61.6K | 496,548 | 0.0% |
| Actavis PLC | SHS | G0083B108 | $60.5K | 293,950 | 0.0% |
| Keryx Biopharmaceut | COMMON | 492515101 | $60.3K | 3,537,590 | 0.0% |
| Shire PLC | SP ADR | 82481R106 | $58.1K | 391,197 | 0.0% |
| Theravance Inc | COMMON | 88338T104 | $57.3K | 1,851,088 | 0.0% |
| Ironwood Pharmaceucl(IRWD) | COM CL A | 46333X108 | $57.2K | 4,642,182 | 0.0% |
| Immunogen Inc(IMGNEUR) | COMMON | 45253H101 | $54.1K | 3,623,786 | 0.0% |
| Oncomed Pharmaceut | COMMON | 68234X102 | $45.3K | 1,347,642 | 0.0% |
| Aegerion Pharmaceu | COMMON | 00767E102 | $43.1K | 934,100 | 0.0% |
| NPS Pharmaceuticals | COMMON | 62936P103 | $42.2K | 1,408,729 | 0.0% |
| Synageva Biopharma | COMMON | 87159A103 | $38.6K | 465,145 | 0.0% |
| Isis Pharmaceuticals | COMMON | 464330109 | $38.1K | 882,101 | 0.0% |
| Merck & Co Inc(MRK) | COMMON | 58933Y105 | $37.9K | 667,537 | 0.0% |
| Illumina Inc(ILMN) | COMMON | 452327109 | $36.4K | 244,989 | 0.0% |
| Clovis Oncology(CLVSEUR) | COMMON | 189464100 | $34.2K | 493,400 | 0.0% |
| Portola Pharmaceutic | COMMON | 737010108 | $31.4K | 1,212,245 | 0.0% |
| Mallinckrodt PLC | SHS | G5785G107 | $28.7K | 452,764 | 0.0% |
| Forest Labs Inc | COMMON | 345838106 | $24.9K | 270,100 | 0.0% |
| Celldex Therapeutics | COMMON | 15117B103 | $24.9K | 1,408,908 | 0.0% |
| PTC Therapeutics I(PTCT) | COMMON | 69366J200 | $24.8K | 947,902 | 0.0% |
| Intercept Pharmace(ICPTUSD) | COMMON | 45845P108 | $24.6K | 74,493 | 0.0% |
| Sagent Pharmaceuti | COMMON | 786692103 | $24.3K | 1,038,504 | 0.0% |
| Insmed Inc(INSM) | COMMON | 457669307 | $22.3K | 1,172,121 | 0.0% |
| United Therapeutics(UTHR) | COMMON | 91307C102 | $22.0K | 234,400 | 0.0% |
| Seattle Genetics Inc | COMMON | 812578102 | $20.2K | 442,819 | 0.0% |
| DR Reddys Labs LTD(RDY) | ADR | 256135203 | $18.9K | 431,612 | 0.0% |
| Valeant Pharma Intl | COMMON | 91911K102 | $17.0K | 128,800 | 0.0% |
| Akorn Inc(AKRXEUR) | COMMON | 009728106 | $16.8K | 761,443 | 0.0% |
| Covidien PLC | SHS | G2554F113 | $15.5K | 209,876 | 0.0% |
| Intuitive Surgic Inc(ISRG) | COMMON | 46120E602 | $14.2K | 32,408 | 0.0% |
| Momenta Pharmaceutic(MNTA) | COMMON | 60877T100 | $12.9K | 1,110,797 | 0.0% |
| Tornier N V | ORDINAR | N87237108 | $9.4K | 442,801 | 0.0% |
| Heartware Intl Inc | COMMON | 422368100 | $9.3K | 99,241 | 0.0% |